ArticlePostepy dermatologii i alergologii2020

Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients.

Dominika Wcisło-Dziadecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.